Results
|
|
1.
|
[Role of pretherapeutic biomarkers in lung cancer with special regards to bronchoscopic procedures]. [electronic resource] by
- Darwiche, K
- Özkan, F
- Ting, S
- Johnen, G
- Brüning, T
- Soltermann, A
- Huber, L C
- Christoph, D C
- Freitag, L
- Franzen, D
Producer: 20150810
In:
Pneumologie (Stuttgart, Germany) vol. 68
Availability: No items available.
|
|
|
2.
|
|
|
|
3.
|
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer. [electronic resource] by
- Fennell, D A
- Summers, Y
- Cadranel, J
- Benepal, T
- Christoph, D C
- Lal, R
- Das, M
- Maxwell, F
- Visseren-Grul, C
- Ferry, D
Producer: 20160706
In:
Cancer treatment reviews vol. 44
Availability: No items available.
|
|
|
4.
|
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer. [electronic resource] by
- Christoph, D C
- Kasper, S
- Gauler, T C
- Loesch, C
- Engelhard, M
- Theegarten, D
- Poettgen, C
- Hepp, R
- Peglow, A
- Loewendick, H
- Welter, S
- Stamatis, G
- Hirsch, F R
- Schuler, M
- Eberhardt, W E E
- Wohlschlaeger, J
Producer: 20130116
In:
British journal of cancer vol. 107
Availability: No items available.
|
|
|
5.
|
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas. [electronic resource] by
- Reis, H
- Herold, T
- Ting, S
- Worm, K
- Huber, U
- Christoph, D C
- Eberhardt, W E
- Kostbade, K
- Kasper, S
- Stamatis, G
- Welter, S
- Darwiche, K
- Karpf-Wissel, R
- Theegarten, D
- Schmid, K W
- Schuler, M
- Wiesweg, M
Producer: 20151201
In:
Lung cancer (Amsterdam, Netherlands) vol. 88
Availability: No items available.
|